monochlorobimane glutathione Screening for recombinant transferases active with is a non Monochlorobimane (CAS 76421-73-3) | Abcam

A critical oversight in many studies is the assumption that oxidative stress is the primary, or sole, cause of the disease in question

For example, some of the therapeutic benefits observed for ebselen could be associated with this activity as it also inhibits NADPH oxidase activity

However, as LDLRs are known to be expressed in normal tissues, off-target effects and systemic toxicity remain concerns, potentially reducing the drug concentration at the intended site

Under neuroinflammatory conditions, dysfunctional mitochondria release ROS and damage-associated molecular patterns (DAMPs) (53), activating microglia and astrocytes, and triggering the release of pro-inflammatory cytokines and chemokines (54), thereby exacerbating the damage

[DOI] [PMC free article] [PubMed] [Google Scholar] 169.Hill W., Lim E.L., Weeden C.E., Lee C., Augustine M., Chen K., Kuan F.C., Marongiu F., Evans E.J., Moore D.A., et al